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INTRODUCTION 
Typhoid fever is a global public health problem,epidemics of typhoid 
fever and high endemic disease rates have been reported in India and countries 
in South Asia,however many cases remain undiagnosed and thus the real 
situation remains unknown.Typhoid fever accounts for an estimated 21 million 
and 200,000 deaths world wide annually
1 
.In 2000 an estimated 5.4 million 
cases of paratyphoid fever occurred globally.These values are from studies 
conducted in high incidence areas and therefore not totally unbiased. 
In India an estimate of annual typhoid incidence rate of 493.5 cases per 
100,000 person years was reported in one study 
2
   
Typhoid fever has a high social and economic impact as a result of 
hospitalization of the patients with acute disease or its complications and 
therefore the loss of income attributable to the duration of the clinical illness.
3
 
In areas of endemicity and in large outbreaks,maximum patients were 
aged between 3 and 19 years.However bacteremic Salmonella typhi infection 
has been reported in children less than 3 years in India,Bangladesh,Nigeria 
etc.
4,5
In Indonesia, 900,000 cases per year and over 20,000 deaths are reported 
to occur.In South America, maximum cases occurred in school going children 
of 5-19 years and also in adults over 35 years of age. 
11 
 
 
Annual incidence of typhoid infection worldwide. 
Between 1% and 5% of typhoid fever patients are reported to end up as 
chronic carriers of infection of gall bladder though it does depend on the age,sex 
and also treatment provided.Chances of ending up as a carrier increases with 
advancing age and is greater in the female sex.
6 
The Complete blood count in enteric fever is said to be 
unremarkable.Leukopenia may be seen in 20-25% cases and the differential 
count demonstrates absolute eosinophilia in 70-80%.However these do not help 
to differentiate enteric fever from other acute bacterial and viral 
infections.Thrombocytopenia may be present in 10-15% usually by 2
nd
 week of 
illness.  
7,8,9 
Definitive diagnosis of typhoid fever is by the isolation of S.typhi from 
blood,bone marrow or a specific anatomical lesion.Blood culture is the mainstay 
12 
 
of diagnosis as more than 80% of the patients with typhoid fever have the 
causative organism in their blood.
10
Bone marrow aspirate culture is said to be 
superior than blood culture for the diagnosis as it is positive even in previously 
treated patients,with long history of illness and for whom there has been a 
negative blood culture with the recommended volume of blood.
11 
Felix-Widal test is performed on acute serum and measures the 
agglutinating antibody levels against O and H antigens.The test has only 
moderate sensitivity and specificity and can be negative in up to 30% of culture 
proven cases of typhoid fever.This can be attributed to prior antibiotic therapy 
that has blunted the antibody response.False positivity may arise as Salmonella 
typhi share O and H antigens with other Salmonella serotypes  and has cross 
reacting epitopes with other enterobacteriacae.In spite of its limitations,the test 
is extremely useful in developing countries as it is simple,cheap and easily 
available.
12,13 
Newer diagnostic tools are available now which provide quicker and 
more reliable diagnoses and could replace Widal test in the future.The Typhidot 
test developed in Malaysia is performed in just 3 hours and detects specific IgM 
and IgG antibodies against a 50kD antigen of S.typhi.It has 75% specificity and 
95% sensitivity and high negative and positive predictive values.Typhidot-M is 
specific for IgM antibodies alone.Evaluation of Typhidot and Typhidot-M in 
13 
 
clinical settings showed that they performed better than Widal test and culture 
method.
14 
 
IDL Tubex test was developed in Sweden and can detect IgM O9 
antibodies within two minutes itself.In a preliminary study involving stored sera 
the test performed better than Widal test in both sensitivity and specificity.
15
 
The Dipstick test is a product of Netherlands and is based on the binding of 
S.typhi specific IgM antibodies in sample to S.typhi lipopolysaccharide (LPS) 
antigen and the staining of bound antibodie by an anti-human IgM antibody 
conjugated to colloidal dye particles.
16,17 
Antimicrobial susceptibility testing is crucial for the guidance of clinical 
management as many isolates are now multidrug resistant 
18,19,20
 
(MDR).Conventionally used drugs like Ampicillin, Chloramphenicol 
,Sulfonamide Trimethoprim, Streptomycin and Tetracycline are now 
resistant.Newer therapy includes fluoroquinolones, 3
rd
 generation 
cephalosporins,monobactum betalactum (aztreonam) and 
macrolides(azithromycin).
 7,21,22
Reduced susceptibility to fluoroquinolones is 
indicated by in vitro resistance to nalidixic acid.This is indicated because of the 
possibility of false in vitro susceptibility against the fluoroquinolone used for 
treatment.
 23,24
The choice of antimicrobial agents for the test is dictated by the 
agents that are currently used for the treatment and also to prevent the 
emergence of MDR strains of Salmonella.
25,26 
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REVIEW OF LITERATURE 
HISTORY
27,28 
The word TYPHOID appears to have its origin from the Greek word 
―TYPHOS‖ which means smokes or stupor,sharing its origin with the disease 
Typhus with which it was once confused.
29 
The first clinical description was given by Thomas Willis in 1659.Budd 
in 1856 described the transmission of the disease through excreta of 
patients.Eberth in 1880 described the typhoid bacillus and Gaffky in 1884 
isolated it in pure culture.
28 
Salmonella paratyphi A was isolated by Gwyn in 1898 while salmonella 
paratyphi B was isolated by Achardo and Bensande in 1896 and they also used 
the term paratyphoid fever.Paratyphi C was isolated by Uhlenhuth and Hubner 
in 1908. 
Widal along with Sicard,introduced the serological agglutination test, 
now popularly known as the Widal test, in France in the year 1896.Felix and 
Pitt described the antigen associated with the virulence of the organism and 
called it Vi antigen. 
The first vaccine was prepared by Pfeiffer and Kolle in 1896 in Germany 
with heat killed organisms.In 1903 Robert Koch outlined three logical methods 
of typhoid control : disinfect the excreta,improve sewage handling,and isolate 
15 
 
convalescent patient until they become bacillus free.In 1948,Theodore 
Woodward showed that Chloamphenicol sterilized the blood cultures of typhoid 
fever patients – thus ushering in the modern era of antibiotics for the treatment 
of typhoid fever.
27,28 
ETIOLOGY
28 
The causative organism is popularly known as Salmonella typhi.It is 
strictly S.enteric, subspecies enteric, serotype typhi and is a robust,gram 
negative bacillus that infects only man and is capable of surviving in hostile 
environments like ice,water,dust and clothes.
3 
They are gram negative rods of 2-4um x 0.6um in size and are non-acid 
fast,noncapsulating,non sporing,motile bacilli with peritrichous flagellae.They 
are aerobic and facultatively anaerobic.They possess 3 important antigens
28,30
: 
i.Polysaccharide envelope antigen known as Vi antigen  
 Though it has no intrinsic virulence,it appears to confer virulence by 
masking the oligosaccharide somatic O antigen from immunological 
attack 
 It may act by coating the bacterial surface and prevent the antibacterial 
and opsonic effect of O antibody 
 It is poorly immunogenic, and only low titres of antibody are produced 
following infection 
16 
 
 Its detection is not useful for the diagnosis and hence is not used in Widal 
test.The persistence of Vi antibody however implies development of 
carrier state. 
ii.Flagellar H antigen   
 
 It is strongly immunogenic and induces antibody formation rapidly and in 
high titre following infections or immunization 
 When mixed with antisera,it agglutinates rapidly to form large, loose, 
fluffy clumps. 
iii.Somatic O antigen 
 It forms part of cell wall and is less immunogenic than H 
antigen,therefore the titre of O antibody induced after an infection or 
following immunization is lower than that of H antibody 
 When mixed with antisera,it forms compact, chalky, granular clumps. 
 
A schematic diagram of a single Salmonella typhi cell showing the 
locations of the H (flagellar), 0 (somatic), and Vi (K envelope) antigens. 
17 
 
S.typhi can acquire R plasmids which endow it with resistance to 
chloramphenicol, amoxicillin and cotrimoxazole.A variety of genes (pho P/pho 
Q, omp R, env Z) have been recently discovered to enable the organisms to 
adapt to changes in the environment such as shifts of pH,osmolality and calcium 
concentration and to withstand the effects of microbicidal proteins (defensins) 
present in the phagosomes of phagocytic cells. 
                       
TRANSMISSION
31,32,33 
Mainly by the faeco-oral route and occasionally by the urine-oral route.It 
may take place directly through soiled hands contaminated with faeces or urine 
of cases or carriers or indirectly by the ingestion of contaminate water,milk 
and/or food or through flies. 
SOURCE OF INFECTION 
It is either the patient or the carriers.Man is the only known reservoir of 
infection.
1,28,30,31 
1. Cases : A patient with fever (38C and above) that has lasted for at 
least 3 days,with a laboratory confirmed positive culture 
(blood,bone marrow,bowel fluid) of  S.typhi Carrier : They may be 
temporary (convalescent/incubatory) or chronic.Patients excrete 
salmonella in the faeces or urine for about a month. 
18 
 
2. Convalescent carrier : Excrete bacilli for 6-8 weeks after which 
their numbers diminish rapidly. 
3. Chronic carriers : They are those who excrete bacilli for more than 
one year after a clinical attack.In most,the organisms persist in the 
gall bladder and bile duct.A chronic carrier state is expected to 
develop in 2-5% of cases.A famous example is the case of Typhoid 
Mary,a cook,who gave rise to more than 300 cases in her lifetime. 
Chronic urinary carrier state is very uncommon and is often 
associated with some abnormality of the urinary tract. 
 
PATHOGENESIS 
The inoculums size required to cause enteric fever is 10
5
-10
9
 S. typhi 
organisms.
3The bacteria invade through Peyer’s patches and are transported to 
intestinal lymph nodes where multiplication takes place within mononuclear 
cells.Monocytes are unable to destroy the bacilli early in the disease process and 
so carry these bacilli to mesenteric lymph nodes.From there the bacilli enter the 
blood stream through the thoracic duct causing a transient bacteremia.These 
circulating bacilli then reach the reticuloendothelial cells in the liver,spleen and 
bone marrow and may seed other organs.After proliferation there,bacteremia 
recurs.The gall bladder is particularly susceptible to infection and local 
19 
 
multiplication occurs there and produces large number of bacilli which reach the 
intestine through the bile.
33-36 
In carriers,large number of virulent bacilli pass to the intestine daily and 
are excreted in stool,without entering the epithelium of the host. 
CLINICAL FEATURES
27,30,31,35,36 
―A case of typhoid fever may present as a disease,clinically 
indistinguishable from malaria,progress to bacillary dysentery,mimic a case of 
acute bronchitis,stimulate a fully fledged case of lobar pneumonina,cause an 
acute abdomen in perforation and then finally,with its evil spent,linger on as an 
orchitis,myocarditis or a peripheral neuritis.‖ 
The above quote gives an idea of the varied presentation of enteric 
fever.Variation of clinical features may depend upon the age, race, religion, 
socioeconomic status, season, sanitation and nutrition. 
Season – Higher incidence is seen in monsoon – from June to 
October,mainly because of contamination of food by flies. 
Sex – Equal incidence is noted in many studies whereas in others there is 
a greater incidence in males.Carrier rate is more in females. 
Age- Incidence is maximum in adolescents and young adults.After the 
age of 20,the incidence falls probably due to acquisition of immunity from 
20 
 
clinical and subclinical infection.The clinical picture in infants and young 
children is non specific, varies significantly and the disease is severe and takes 
longer time for recovery.The clinical profile in older children and adolescents is 
similar to that in adults.A study by Sinha A,Sazawal S,Kumar R et al in 1999 
concluded that typhoid is a significant cause of morbidity between 1 and 5 years 
of age.
4 
Mode of onset – It could be typical,as seen frequently in older children and 
adults,or atypical,as seen more in infancy and childhood. 
Typical onset: It is normally insidious with malaise as a vague but typical 
presenting symptom.Chills are common though rigors are not.They usually have 
headache which is nagging and persistent.Generalised aching in muscles and 
joints,abdominal pain,diarrhea more common than constipation are some other 
features.Cough,sore throat and poor appetite with a generalized feeling of 
unwellness are also seen. 
Atypical presentation : Here the onset may be abrupt with the patient 
worsening considerably within a day or two with symptoms suggesting 
septicemia due to streptococci and pneumococci.Pneumo-typhoid is when 
patient has acute lobar pneumonia and S.typhi may be isolated from the 
sputum.Sometimes mental symptoms like states of confusion,  stupor, psychosis 
or even coma may dominate.Typhoid nephritis is rare with urinary 
symptoms,renal pain and hematuria.Abdominal pain may be severe enough to 
21 
 
suspect appendicitis,when a leucocye count may help to distinguish.Gall bladder 
pain is more common in convalescence.Jaundice is rare but cases have been 
reported with jaundice presenting in first week and associated with hematuria 
and other forms of hemorrhage.Early presentation of symptoms of acute 
peritonitis,due to perforation of intestine is also uncommonly seen. 
Ambulant or latent form – Seen in children with insidious onset when they 
present with complications like convulsions, delirium or signs of intestinal 
perforation or hemorrhage. 
Fever : Studies show that 60% have continuous fever while the rest may 
have intermittent,remittent or irregular fever.Chills is common whereas rigors is 
not.Step ladder pattern of fever is classically described in typhoid and is one 
which climbs by about 2⁰F in the evening and falls 1⁰F in the morning so that 
by the end of 5 days it has reached a plateau of between 102-104⁰F above which 
it rarely descends.However this pattern is rarely seen in children.
37,38 
Other clinical signs include expressionless appearance of the 
patient,delirium,coated tongue that spares the tips and edges,disended 
abdomen,mild hepatosplenomegaly and presence of coarse crepitations and 
rhonchi on auscultation.Relative bradycardia may occur in less than half of the 
patients.
39 
22 
 
The characteristic rose spots are rashes that appear in crops from 7
th
 to 
10
th
 day,first upon the abdomen and then on the thorax and extremities.They are 
flattened papules that disappear on pressure with diameter of 2-4mm.After 
persisting for 2-3 days they disappear leaving a brownish stain.They are also 
present in the typical relapse.On the Indian skin however such spots are not 
easily recognized. 
Complications usually arise in the second week.
37,38
By the third 
week,patient may lapse into the typhoid state where he may be disoriented and 
toxemic,sleepless,confused and muttering and is also called ―muttering delirium 
or coma vigil‖.Pulse may become thread,respiration shallow and 
rapid.Expressionless face known as Hippocrates facies reflects profound 
toxemia.Payers patches may become necrotic and ulcerative and bleeding or 
perforation may occur.At this stage the so called ―pea soup diarrhea‖ may 
appear.  
Death may occur from overwhelming toxemia, myocarditis, intestinal 
hemorrhage or perforation.
18,20,40 
Those who survive into the 4
th
 week may show an improvement of symptoms 
and signs but intestinal complications may occur and convalescence 
prolonged.This is the week of convalescence. 
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COMPLICATIONS: 
20,41,42 
i) GASTROINTESTINAL COMPLICATIONS 
 Intestinal Hemorrhage 
 Intestinal perforation 
 Paralytic ileus or meteorism 
2) HEPATOBILIARY COMPLICATIONS41,42 
 Acute cholecystitis 
 Chronic cholecystitis and carrier state 
3) CENTRAL NERVOUS SYSTEM COMPLICATIONS42,43 
 Neuropsychiatric complications 
 Typhoid meningitis 
4) HEMATOLOGICAL COMPLICATIONS7,8 
 Anemia 
 Leucopenia/ Leucocytosis 
 Hemolytic anemia 
 Disseminated Intravascular Coagulation 
5) RESPIRATORY COMPLICATIONS 
 Bronchitis 
 Typhoid pneumonia 
 Laryngitis 
 Acute Respiratory Distress Syndrome 
24 
 
6) CARDIOVASCULAR COMPLICATIONS 
 Myocarditis42,43 
 Venous thrombosis 
7) MUSCULOSKELETAL COMPLICATIONS 
 Periostitis of tibia or ribs 
 Typhoid arthritis 
 Typhoid osteomyelitis – more common in patients with sickle cell 
disease 
 Abscess formation in bones 
8) GENITOURINARY COMPLICATIONS 
 Renal failure 
 Nephritic syndrome 
 Suppurative typhoid pyelonephritis 
 Typhoid cystitis 
 Typhoid orchitis 
9) POST TYPHOID ANHIDROSIS 
10) ABSCESS FORMATION – commonest is pelvis abscess. 
11) MISCELLANEOUS 
 Parotitis 
 Pancreatitis 
 Thyroiditis 
25 
 
DIFFERENTIAL DIAGNOSES
31,36,38 
 Malaria 
 Miliary tuberculosis 
 Hepatitis 
 Leptospirosis 
 Rickettsial diseases 
 Tularemia 
 CMV infections 
 Lymphomas 
 Vasculitis 
 
DIAGNOSTIC INVESTIGATIONS
44 
Diagnostic test Sensitivity 
range (%) 
Sensitivity 
range (%) 
Comments 
Microbiological 
tests 
   
Blood culture 40-80 NA Widely regarded as the gold 
standard, but sensitivity may be 
low in endemic areas with high 
rates of antibiotic use—hence 
26 
 
true specificity is difficult to 
estimate 
Bone marrow 
culture 
55-67 30 Greater sensitivity but invasive 
and thus of limited clinical 
value, 
especially in ambulatory 
management 
Urine  culture 0-58 NA Variable sensitivity 
Stool culture 30 NA Sensitivity lower in developing 
countries and not used routinely 
for follow-up 
Molecular 
diagnostics 
   
Polymerase chain 
reaction 
100 100 Promising, but initial reports 
indicated similar sensitivity to 
blood 
cultures and lower specificity 
Nested polymerase 
chain reaction 
100 100 Promising and may replace 
blood culture as the new ―gold 
standard 
  
27 
 
Serological 
diagnosis
 
   
Widal test (tube 
dilution and slide 
Agglutination)
 
47-77 50-92 Classic and inexpensive. 
Despite mixed results in 
endemic areas, 
still performs well for screening 
large volumes. May need 
standardisation and quality 
assurance of reagents 
Typhidot
 
66-88 75-91 Lower sensitivity than 
Typhidot-M 
Typhidot-M
 
73-95 68-95 Higher sensitivity and 
specificity than classic Typhidot 
in some 
series, but other evaluations 
suggest that the performance 
may 
not be as robust in community 
settings as in hospital 
  
28 
 
Tubex
 
65-88 63-89 Promising initial results but has 
yet to be evaluated in larger 
trials 
in community settings 
Others    
Urine antigen 
detection 
65-95 NA Preliminary data only 
 
MICROBIOLOGICAL TESTS 
1) BLOOD CULTURE : S.typhi is cultured from venous blood in 90% of the 
cases during the first 10 days of the disease.Sensitivity reduces to 50% by 3
rd
 
week.Addition of Ioquoid (sodium polyanethol sulfonate) counteracts the 
bactericidal action of blood.
1,28,31,32,33,45
 
                               
CLOT CULTURE : Here the blood collected is allowed to clot before 
culturing as the bactericidal property of blood seems to be concentrated 
29 
 
mainly in the serum.Therefore clot culture may be positive in cases where 
the blood culture is negative.Sensitivity is 69-84%.
11,28 
2) BONE MARROW CULTURE : It is more specific than blood culture as 
the organisms can live after it has left the blood stream especially in those 
who are treated with antibiotics.It is used to find the antibiotic sensitivity or 
phage type of a strain causing outbreak.
46
It is indicated in  prolonged febrile 
illness of unknown origin and in those with severe prolonged 
neutropenia.However its invasive nature does not make it the gold 
standard.
45
 
3) STOOL CULTURE : Its positivity increases more in the 3rd week as 
compared to the 1
st
.It is taken from a properly sterilized bed pan in a special 
container.Rectal swabs are not useful in diagnosis.Successful culture 
depends on the use of enrichment media like McConkey and Wilson Blair 
media,as the salmonella are greatly outnumbered in the faeces by normal 
flora.Carriers may also demonstrate a positive culture. 
4) URINE CULTURE : It is positive in a quarter to one third of the cases but 
there seems to be no regular excretion pattern as in faeces
47
.Bacteruria is 
usually temporary but if it persists and person becomes a urinary carrier,then 
a preceding urinary tract abnormality should be suspected.
28,31,45
 
5) BILE CULTURE : It may give positive results more than blood and is 
especially reliable in determination of carrier state.A convenient method is 
by string capsule devise or duodenal intubation during endoscopy.
31,45
 
30 
 
6) ROSE SPOTS CULTURE : Since the occur as the result of embolisation of 
bacteria,skin snips can be cultured especially in patients who have take 
antibiotics.
31,46
 
7) MISCELLANEOUS : S.typhi  has been isolated from cerebrospinal fluid, 
peritoneal fluid, mesenteric lymphnodes, pharynx, tonsils and 
abscesses.
28,31,42
 
Antimicrobial susceptibility testing is crucial for the guidance of clinical 
management as many isolates are now multidrug resistant 
18,19,20
 
(MDR).Conventionally used drugs like Ampicillin, Chloramphenicol 
,Sulfonamide Trimethoprim, Streptomycin and Tetracycline are now 
resistant.Newer therapy includes fluoroquinolones, 3
rd
 generation 
cephalosporins,monobactum beta lactum (aztreonam) and 
macrolides(azithromycin).
 7,21,22 
Reduced susceptibility to fluoroquinolones is 
indicated by in vitro resistance to nalidixic acid.This is indicated because of the 
possibility of false in vitro susceptibility against the fluoroquinolone used for 
treatment.
 23,24
The choice of antimicrobial agents for the test is dictated by the 
agents that are currently used for the treatment and also to prevent the 
emergence of MDR strains of Salmonella.
25,26.
In vitro susceptibility testing 
usually involves disc diffusion. 
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BACTERIOPHAGE TYPING : This is especially important in 
epidemiological differentiation of organisms producing outbreaks and for the 
identification of the source.
28,31,42 
SEROLOGICAL TESTS 
1)WIDAL TEST : This test measures the H (flagellar) and O (osmotic) 
agglutinins for typhoid and paratyphoid bacilli in patient’s sera.By the end of 
first week of illness the antibodies tend to appear and show progressive rise in 
the titers as the disease advances.
1,9,12,13,40 
PRINCIPLE: Agglutinins against H (flagellar) and O (somatic) antigens of 
Salmonella group of organisms were detected quantitatively employing killed 
suspension of appropriate organisms. 
PROCEDURE: 
1.For each test sample, arrange four rows of 6 tubes in a rack. 
2.Prepare master dilutions by taking 5 tubes in another rack,place 7ml of normal 
saline in the first tube and 3.5ml in the remaining 4 tubes.Add 0.5ml of serum to 
the first tube and mix well.Transfer 3.5ml from the first tube to the next tube 
and mix well.Continue successive transfer of 3.5ml quantities till the last tube is 
reached.This will give final dilution of 1:30, 1:60, 1:120, 1:240 and 1:480 after 
the addition of antigen in step 4.
9,28 
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3.Transfer 0.5ml quantities from the master dilution tubes to each tube of the 
corresponding vertical row in test rack.Place 0.5ml of normal saline in each of 
the tubes in the last i.e. 6
th
 row to serve as controls. 
4.To each of the 6 tubes in the first 4 horizontal rows,add 0.5ml of Salmonella 
typhi O, S. typhi H, S.paratyphi A (H) and S.paratyphi B (H) antigens 
respectively. 
5.Shake the rack well to mix and incubate at 37⁰C overnight. 
6.Note the highest dilution in which there is evidence of agglutination as 
observed by the naked eye.With H antigens the agglutination is floccular cotton 
wool type and with O antigens it is fine granular and appears as granular matt at 
the bottom of the tube. 
INTERPRETATION: 
1..The agglutination titer will depend on the stage of disease.Agglutins will 
usually appear by the end of the first week,so that blood taken earlier may give 
a negative result.The titer increases steadily till the third or fourth week after 
which it declines gradually.
28 
2.Agglutination titers of TO=1:80 are significant and the rise in titers after 
repetition of the Widal test after a few day will confirm enteric fever diagnosis. 
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3.Agglutination titers of TH=1:160 and above are typically found in cases of 
enteric fever. 
4.Those with history of prior infection or immunization may develop an 
anamnestic response during an unrelated fever.This may be differentiated by 
repetition of Widal test after a week.The anamnestic response shows only a 
transient rise,while in enteric fever the rise is sustained. 
5.A moderate rise in the titer of all the H agglutinins simultaneously against all 
H antigens is suggestive of a recent TAB vaccination. 
2)TYPHIDOT 
It is an enzyme immunoassay that detects IgG and IgM antibodies against a 
50KD outer membrane protein distinct from the somatic (O), flagellar (H) or 
capsular (Vi) antigen of Salmonella typhi.IgM detection reveals acute typhoid in 
the early phase of infection,while the detection of both IgG and IgM suggests 
acute typhoid in the middle phase of infection.In areas of high endemicity where 
the rate of typhoid transmission is high the detection of specific IgG increase.
1,9 
Typhidot-M detects specific IgM antibodies only. 
3)ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 
It is used to detect Vi antigens in the urine of patients.Vi antibodies typically 
rise after 3-4 weeks of illness and are of less value in the early diagnosis of the 
34 
 
illness.It can be done in polystyrene tubes (Macro ELISA) or poly vinyl 
microtitre plates (Micro ELISA).
6,9,32 
4)TUBEX TEST 
It is based on detecting antibodies to a single antigen in S.typhi only.The 09 
antigen used in this test is very specific,found in only sero group D 
salmonellae.A positive result always suggest a salmonellae infection but not 
which group D salmonella is responsible.Infection by other serotypes like S. 
paratyphi A give negative result.It detects IgM antibodies and so is useful in 
diagnosis of current infections.
1,9 
5)IgM DIPSTICK TEST 
This test is based on the binding of S.typhi specific Ig antibodies to  S.typhi 
lipopolysaccharide (LPS) antigen and the staining of bound antibodies by an 
antihuman IgM antibody conjugated to colloidal dye particles.It is useful in 
places where culture facilities are not available as it can be performed without 
formal training and in the absence of specialized equipments.The sensitivity of 
this test increases with time.
1,9,28 
6)COUNTER IMMUNOELECTROPHORESIS (CIE) 
It is done using veronal buffer extract and detects the lipopolysaccharide and 
surface protein antigens of S.typhi.It is more reliable and specific for serological 
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diagnosis of typhoid fever than Widal but they have the same disadvantages as 
Widal.
1,9 
MOLECULAR DIAGNOSTICS 
1)POLYMERASE CHAIN REACTION 
PCR methods targeting the flagellin gene,somatic gene, Vi antigen gene, 5S-
23S spacer region of the ribosomal RNA gene, INVA gene, flic gene, Hi1 A 
gene of Salmonella typhi for diagnosis of typhoid fever have been evaluated 
with excellent sensitivity and specificity compared to positive (blood culture 
proven) and healthy controls.The turn-around time for diagnosis has been less 
than 24hr.A disadvantage is that the result in those with past history of 
typhoid,carrier,those vaccinated and are culture negative but yielding a PCR 
positive result may in fact be false positives.It is also costly and requires 
sophisticated instruments.
1,9,28,49 
MISCELLANEOUS INVESTIGATIONS
31,32,33,35,36
: 
1) Hemoglobin – May be low and the most common anemia encountered is 
mild normocytic normochromic anemia. 
2) WBCs – Leucopenia of 3000-4000 cells is characteristic of the febrile 
phase of enteric fever.A sudden increase in count to 10,000 cells/cumm 
or higher should suggest the possibility of intestinal 
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perforation,hemorrhage or a pyogenic complication. Eosinopenia may be 
seen due to trapping of eosinophils in reticuloendothelial system.
9
 
3) Platelets – Thrombocytopenia may be seen.9 
4) ESR – is usually elevated. 
5) Urine routine – Hematuria and proteinuria with casts may be seen in 
cases of Nephrotyphoid. 
6) Chest Xray – features of typhoid pneumonia or ARDS 
7) USG Abdomen – features of silent perforation or pelvic abscess 
formation 
8) DIC profile – PT, PTTK, serum fibrinogen and FDP levels may be 
elevated secondary to typhoid hepatitis and/ or septicemia. 
9) Serum electrolytes and arterial blood gases – hypokalemia and 
hyponatremia may be seen. 
10) Renal function tests – Acute renal failure may be seen in peripheral   
circulatory shock (due to septicemia or myocarditis) and typhoid  
nephritis. 
11) Bone marrow – this is evaluated in patients with prolonged   
pancytopenia and for culture when the diagnosis is in doubt. 
12) Adenosine deaminase enzyme (ADA)- is raised in typhoid though it is 
not specific. 
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TREATMENT 
Both general and specific measures play important roles in the treatment 
of typhoid fever. 
By general measures we mean adequate hydration and nutrition, 
antipyretics, prevention and control of spread. Specific measures implies the use 
of antibiotics. 
Antibiotic therapy 
Conventionally used drugs like Ampicillin, Chloramphenicol 
,Sulfonamide Trimethoprim, Streptomycin and Tetracycline are now 
resistant.However due to change in sensitivity and the pattern of bacterial 
infection,wide spread occurrence of multi drug resistant typhoid fever has been 
reported from South East Asia and Indian subcontinent.Newer therapy includes 
fluoroquinolones (ciprofloxacin,ofloxacin,pefloxacin etc.), 3
rd
 generation 
cephalosporins (eg. Ceftriaxone,cefotaxime, ceftazidime, 
cefoperazone),monobactum beta lactum (aztreonam) and 
macrolides(azithromycin).
 7,21,22 
In randomized controlled trials involving patients infected with 
quinolone-susceptible S.enterica serotype typhi,quinolones have proved safe in 
all age groups and are rapidly effective even with short course of treatment (3-7 
days).Cure rates exceed 96% and less than 2 percent of treated patients have 
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persistent fecal carriage or relapse.
50
 On routine drug sensitivity testing some 
strains of S.typhi may show susceptibility to fluoroquinolones but show poor 
clinical response on actual treatment.However these same strains may show 
resistance to nalidixic acid on sensitivity testing.Therefore if the isolate shows 
resistance to nalidixic acid then it implies a higher MIC for fluoroquinolones 
and thus higher doses of fluoroquinolones are required for effective treatment. 
Patients with enteric fever due to isolates with decreased ciprofloxacin 
susceptibility are more likely to have prolonged fever clearance times and 
higher rates of treatment failure .
24,25,51 
Since the clinical cure rate reported with Ceftriaxone,the most commonly 
used 3
rd
 generation cephalosporin for typhoid, is above 90% according to 
various authors,it is being given commonly for typhoid.However many are of 
the opinion that it is better  to give them as first line only for complicated 
cases.Ceftriaxone is also known to keep the relapse rate lower and prevent 
carrier state.
52
 
Chowta MN,Chowta NK conducted a retrospective study on clinical 
profile and antibiotic sensitivity in 1999-2001 and concluded that resistance of 
Salmonella typhi to Amoxicillin, Ampicillin, Chloramphenicol and 
Cotrimoxazole were significantly high.Ciprofloxacin showed resistance of 18% 
and Cephalosporins were 100% sensitive.  
53 
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Yaramis A,Yildirim I,Katar S et al conducted a study on 314 children 
admitted to the Dicle University Hospital and revealed resistance rates of 17% 
for Ampicillin,5% for trimethoprim-sulfamethoxazole,4% for ceftriaxone and 
6% for sulbactam-ampicillin.No resistance was detected against quinolones and 
chloramphenicol.
54 
Jog S,Soman R,Singhal T et al conducted a retrospective chart review on 
enteric fever in a hospital in Mumbai and concluded that there was a high 
culture positivity despite receipt of prior antibiotics,high prevalence of nalidixic 
acid resistance (79%),return of susceptibility to chloramphenicol (96%),100% 
sensitivity to ceftriaxone and non superiority of combination therapy versus 
single agent therapy.
55 
Walia M,Gaind R et al undertook a retrospective analysis of blood 
culture-confirmed cases of enteric fever diagnosed at Safdarjang Hospital, New 
Delhi, India from 2001-2003 and concluded that  there was a significant decline 
in MDRS from 21.9% in 2001 to 12.4% in 2003 with a significant increase in 
nalidixic acid-resistant Salmonella (NARS) from 56.9% in 2001 to 88.9% in 
2003 . Minimal inhibitory concentrations (MICs) of ciprofloxacin for NARS 
were increased but were within National Committee for Clinical Laboratory 
Standards susceptibility ranges. 
56 
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A prospective randomized controlled parallel study was conducted in 
2007 by Kumar R,Gupta N and Shalini on 93 children of age upto 12 years  
with blood culture proven S.typhi to evaluate multi drug resistant typhoid fever 
and therapeutic response of ofloxacin and ceftriaxone.Those children treated 
with ceftriaxone had a shorter time to defervescence compared to ofloxacin with 
a mean of 4.258 and 4.968 respectively.
24 
Frenck RW Jr.,Mansour A,Nakhla I et al conducted a study in Cairo on 
149 children and adolescents between 3 and 17 years age with clinical 
typhoid.They were treated with either oral Azithromycin or intravenous 
Ceftriaxone daily for 5 days.Cure was achieved in 94% of patients  treated with 
Azithromycin and 97% of patients treated with Ceftriaxone.Azithromycin group 
took longer time to clear bacteremia and had no case of relapse when compared 
with the Cefriaxone group.They concluded that a 5 days course of Azithromycin 
is an effective treatment for uncomplicated typhoid fever in children and 
adolescents.
57 
Butler T,Sridhar CB,Daga MK et al conducted a randomized open trial in 
4 hospitals in India on Azithromycin versus Chloramphenicol for treatment of  
enteric fever.The results indicated that azithromycin given once daily for 7 days 
was effective therapy for typhoid fever in a region endemic with 
chloramphenicol- resistant  S.typhi infection and was equivalent in effectiveness 
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to chloramphenicol given to patients with chloramphenicol-susceptible 
infections.
58
 
Treatment of carriers  
Amoxicillin in the dose of 100mg/kg in three divided doses daily for 3 
months or Trimethoprim-Sulfamethoxazole for 3 months or Ciprofloxacin for 
four weeks have cure rates of more than 80%.The high concentrations of 
amoxicillin and fluoroquinolones in bile and the superior intracellular 
penetration of fluoroquinolones put them at an advantage compared to 
trimethoprim-sulfamethoxazole.In cases of combined anatomic 
abnormalities,surgery also is required for eradication.Those with urinary 
carriage associated with schistosomiasis haematobium have to be treated with 
praziquantel also.To be considered a non-carrier,stool cultures are to be 
repeated weekly till  3 consecutive negative cultures are obtained.
59 
Prevention and control
28,31,33 
There are 3 steps of defence against typhoid: 
 Limit the infectivity of sources 
 Prevent transmission of disease 
 Immunization 
Limit the infectivity of cases and carriers by early diagnosis,isolation, adequate 
treatment and disinfection and then proper follow up.
28,32,33 
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The cases and carriers should not be allowed to handle food and water for 
others.Proper health education has an important role as something as simple as 
washing hands with soap may come a long way in prevention of spread of the 
disease.Improvement in basic sanitation is a must.
33 
Immunization 
33,59 
It is the only specific preventive measure though it does not give 100% 
protection,it definitely lowers the incidence and morbidity.It is recommended in 
endemic areas and those travelling to endemic areas,household contacts of 
carriers,groups at risk like school going children and laboratory workers.
9,33 
Heat killed whole organisms S.typhi has been the mainstay of treatment 
for long. 
Heat phenol inactivated vaccine manufactured by Wyeth (TAB) is given 
as two 0.25ml subcutaneous injections separated by more than 4 weeks for 
children older than 6 months to 10 years of age.For those older than 10 years 
0.5ml injections are given.Booster doses have to be given every 3 years.In 
India,a divalent typhoid-paratyphoid A vaccine or the monovalent typhoid 
vaccine is preferred.
33,59 
Acetone inactivated vaccine is preferred in endemic areas as they have 
higher efficacy due to preservation of Vi antigen in this preparation.However it 
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is expensive and has more side effects.It is only available to US military 
personnel
33
. 
Typhoral or live attenuated oral vaccine Ty21a is given in the form of an 
enteric coated capsule.4 doses are given 1 hour before meal with cool liquid on 
alternate days.Not recommended for children less than 6 years,the 
immunosuppressed and those on antibiotic therapy especially sulphonamides 
and antimalarial mefloquine therapy.Booster may be given after 3 years. 
A caspsular polysaccharide vaccine ViCPS (TyphimVi) is given as a 
single 0.5ml dose intramuscularly.Booster every 2 years.Not recommended in 
children less than 2 years of age. 
A recently introduced conjugate Vi vaccine formed by fusion of the Vi 
polysaccharide to a non-toxic recombinant Pseudomonas aeruginosa exotoxin A 
(Vi-r EPA) is given in a two dose regimen to children between 2 and 5 years of 
age.It also has the potential to be immunogenic in children aged less than 2 
years and therefore may be incorporated into the WHO extended programme on 
immunization in endemic areas.However it is not commercially available at 
present
59
. 
In 2003,a randomized controlled study conducted by Saha MR,Dutta 
P,Patil A et al on susceptible age group for typhoid fever with Vi antigen 
vaccine and Ty21a vaccine proposed to immunize younger children less than 3 
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years in first phase to arrest infection and advocated the administration of 
subsequent booster dose in potentially endemic population.
5 
The clinical profile and blood picture is changing nowadays because of 
the emergence of multiresistant strains.Appropriate antibiotic treatment is 
critical to curing typhoid with minimal complications.This in turn makes the 
prognosis better. Such a study hopes to find the new trends in clinical profile 
and blood picture in the local population and also which antibiotics are more 
useful in cases of enteric fever at the moment & thus better the prognosis.  
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AIM OF THE STUDY 
 
Primary Aim:   
To determine the blood profile  and blood culture  sensitivity of  
Salmonella typhi and comparison of  Widal with blood culture in Paediatric 
patients of  PSG IMS & R 
Secondary Aim: 
To assess the microbiological profile of Salmonella typhi especially with 
reference to Nalidixic acid 
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MATERIALS AND METHODS 
 This is a retrospective observational study conducted among :  Inpatients 
and outpatients  of department of Paediatrics of PSG IMSR  with 
confirmed diagnosis of Salmonella typhi including locales in and around 
Coimbatore including referred cases.Case records from January 2009 to 
December 2012 were collected and analysed. 
 It is a cross-sectional,hospital based study spanning over a period of 18 
months from June 2011 to November 2012. 
 Study Design 
 
Paediatric Patients
Positive blood culture for 
Salmonella typhi
Culture sensitivity pattern 
especially Nalidixic acid 
Clinical profile and Blood 
profile including ESR
Widal test
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 Inclusion criteria included  
 Children  ≤15 yrs with Blood Culture Positive for Salmonella typhi 
of both sexes. 
 Exclusion criteria included 
   Immunocompromised children 
 Case sheets of  50 patients, from January 2009 to December 2012,fitting 
into the inclusion and exclusion criteria were selected . 
 Several data were collected including Clinical features, Culture 
sensitivity pattern,blood analysis including ESR and Widal test. 
 Blood culture was performed  by collecting 5cc venous blood and 
diluting it 4 times under normal circumstances and 10 times if treated 
with antibiotics,and then injecting into a bulb containing 20-30cc of 5% 
bile broth.The bulb is incubated for 24-48 hrs ar 37⁰C  and subcultures 
are made on McConkey’s medium.Cultures are declared negative after 
incubation for 10 days. 
 Antibiotic sensitivity pattern was assessed by the  Kirby-Bauer disc 
diffusion method where discs containing antibiotics are placed onto an 
agar plate upon which bacteria are growing. If the bacteria are sensitive to 
the antibiotic,a zone of inhibition is seen around the disc. 
 Widal test was done by adding 0.5ml of Salmonella typhi O,Salmonella 
typhi H,Salmonella paratyphi A(H) and Salmonella paratyphi B(H) 
antigens respectively to test tubes with diluted sera of 
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1:30,1:60,1:120,1:240 and 1:480 concentration and also control of 0.5ml 
normal saline.After shaking the rack well,it is incubated at 37⁰C 
overnight.Then with naked eye,the highest dilution in which there is 
evidence of agglutination is noted. 
 Temperature was recorded using mercury/ digital thermometer and noting 
the axillary reading in ⁰F.  
 
• The data collected was then analysed using mainly Descriptive statistics 
and Chi square analysis 
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OBSERVATION AND RESULT 
 
86 cases records of patients treated as Typhoid fever were selected.Of 
them 36 cases were discarded if  blood culture was either not done or were 
negative, or  were partially treated cases.All cases of paratyphoid infection were 
also discarded.Thus 50 cases with blood culture positive for Salmonella typhi 
were chosen and data collected and analysed.The observations were as follows.  
50 
 
AGE DISTRIBUTION 
AGE IN YEARS NO. OF CASES 
(n=50)S 
PERCENTAGE (%) 
0-5  11 22 
6- 10 13 26 
11-15 26 52 
TOTAL 50 100 
 
 
Of the 50 cases included in the study,a majority of 26 cases (52%) fell in the age 
group of 11-15 years.13 cases or 26% were of the 6-10 years age group and 11 
cases or 22% were of the 0-5 years age group.Therefore maximum cases were 
of the school going age group and implies the importance of preventing typhoid 
fever in that group by immunization.  
0-5 YRS
22%
6-10 YRS
26%
11-15 YRS
52%
AGE DISTRIBUTION
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SEX DISTRIBUTION 
SEX NO. OF CASES 
(n=50) 
PERCENTAGE (%) 
MALE 36 72 
FEMALE 14 28 
TOTAL 50 100 
 
 
In our study,36 cases or 72% of the cases were males and only 14 cases or 28% 
were females.Thus it is more common among males. 
MALE
72%
FEMALE
28%
SEX DISTRIBUTION
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AGE WITH SEX DISTRIBUTION 
AGE IN YEARS 
(n=50) 
MALE FEMALE TOTAL 
0 – 5  7 4 11 
6 – 10 10 3 13 
11 - 15 19 7 26 
TOTAL 36 14 50 
 
 
Out of the 50 cases included in the study, majority or 26 of the cases were of the 
age group 11-15 years and of them 19 were male and only 7 were female.In all 
3 selected age groups,males were the majority.   
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DURATION OF FEVER  
DURATION OF 
FEVER IN DAYS 
NO. OF CASES 
(n=50) 
PERCENTAGE (%) 
1-7 34 68 
8-14 11 22 
>14 5 10 
TOTAL 50 100 
 
 
34 of the 50 cases ie 68% had fever of 1-7 days.Only 5 cases or 10% had fever 
of more than 2 weeks duration.11 cases or 22% had fever of 8-14 days duration.  
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PRESENTING SYMPTOMS 
SL. 
NO. 
SYMPTOMS NO. OF CASES 
(n=50) 
PERCENTAGE 
(%) 
1 FEVER 50 100 
2 CHILLS 6 12 
3 NAUSEA 2 4 
4 VOMITING 23 46 
5 HEADACHE 5 10 
6 LOSS OF APPETITE 3 6 
7 DIARRHEA 12 24 
8 CONSTIPATION 0 0 
9 PAIN ABDOMEN 11 22 
10 G.I. BLEED 0 0 
11 SKIN RASH 0 0 
12 COUGH 14 28 
13 JOINT PAINS 1 2 
14 DYSURIA 2 4 
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All the cases presented with fever of which 12% also had associated chills. 
Vomiting was a complaint in 46% ,diarrhoea was seen in 24% and pain 
abdomen was present in 28%.Cough was also seen in 28%.Few cases also 
reported nausea (4%),headache (10%),loss of appetite (6%),joint pains (2%) and 
dysuria (4%).None of  the cases had constipation,GI bleed or skin rashes. 
 
 
50
6
2
23
5
3
12
0
11
0 0
14
1
2
0
10
20
30
40
50
60
PRESENTING SYMPTOMS
56 
 
CLINICAL SIGNS 
SL. 
NO. 
SIGNS NO. OF CASES 
(n=50) 
PERCENTAGE 
(%) 
1 PYREXIA 50 100 
2 TOXIC LOOK 8 16 
3 COATED TONGUE 3 6 
4 PALLOR 2 4 
5 JAUNDICE 1 2 
6 ROSE SPOTS 0 0 
7 LYMPHADENOPATHY 0 0 
8 HEPATOMEGALY 24 48 
9 SPLENOMEGALY 13 26 
10 JOINT SWELLING 1 2 
11 CHEST SIGNS 0 0 
12 CNS COMPLICATIONS 0 0 
13 CVS COMPLICATIONS 0 0 
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All the cases had pyrexia though only 16% had a toxic look.Coated tongue was 
seen in 3 cases(6%),pallor in 2 cases (4%) and jaundice in 1 case 
(2%).Hepatomegaly was a feature in 24 cases or 48% and splenomegaly in 13 
cases or 26%.1 case had joint swelling.None of the cases included had rose 
spots,lymphadenopathy, chest signs, CNS or CVS complications. 
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CLINICAL SYMPTOMS IN DIFFERENT AGE GROUPS 
Vomiting as a symptom was more common in the age group 6-10yrs 
old.Diarrhoea was less common in 0-5 yrs old compared to the other 2 age 
groups.Pain abdomen was a complaint mainly in the 6-10 yrs and 11-15 yrs age 
group.Cough was most common in 11-15 yrs old.Joint pain and dysuria were 
seen only in 6-10 yrs age group.  
SL. 
NO. 
SYMPTOMS NO OF CASES (n=50) 
0-5 YRS 6-10YRS 11-15YRS 
1 FEVER 11 13 26 
2 CHILLS 3 2 1 
3 NAUSEA 1 1 0 
4 VOMITING 6 12 5 
5 HEADACHE 2 2 1 
6 LOSS OF 
APPETITE 
1 1 1 
7 DIARRHEA 2 5 5 
8 CONSTIPATION 0 0 0 
9 PAIN 
ABDOMEN 
1 6 4 
10 G.I. BLEED 0 0 0 
11 SKIN RASH 0 0 0 
     
12 COUGH 3 4 7 
13 JOINT PAINS 0 1 0 
14 DYSURIA 0 2 0 
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CLINICAL SIGNS IN DIFFERENT AGE GROUPS 
SL. NO. SIGNS NO. OF CASES (n=50) 
0-5YRS 6-10YRS 11-15YRS 
1 PYREXIA 11 13 26 
2 TOXIC LOOK 2 2 4 
3 COATED TONGUE 1 2 0 
4 PALLOR 0 2 0 
5 JAUNDICE 0 1 0 
6 ROSE SPOTS 0 0 0 
7 LYMPHADENOPATHY 0 0 0 
8 HEPATOMEGALY 9 8 7 
9 SPLENOMEGALY 2 4 7 
10 JOINT SWELLING 1 0 0 
11 CHEST SIGNS 0 0 0 
12 CNS 
COMPLICATIONS 
0 0 0 
13 CVS 
COMPLICATIONS 
0 0 0 
Splenomegaly was more common in 11-15 yrs age group.Pallor and jaundice 
were noted only in 6-10yrs age group.Joint swelling was found in only 1 case 
and was of 0-5 yrs age group.Most other signs had almost equal aedistribution. 
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TEMPERATURE PROFILE AT TIME OF ADMISSION 
TEMPERATURE 
(⁰F) 
NO. OF CASES 
(n=50) 
PERCENTAGE 
(%) 
<99 2 4 
99 – 100 17 34 
100.1 – 101 15 30 
101.1 – 102 13 26 
102.1 – 103 3 6 
103.1 – 104 0 0 
>104 0 0 
 
 
4% of cases had no fever at admission.34%5 had temperature between 99-100 
⁰F,30% had fever between 100.1-101 ⁰F and 26% had fever between 101.1-102 
⁰F.Therefore most of the cases had temperatures falling within 99-102⁰F.None 
of the cases had temperatures more than 103 ⁰F.  
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BLOOD PROFILE 
HEMOGLOBIN NO. OF PATIENTS 
(n=50) 
PERCENTAGE (%) 
 <=10g% 9 18 
 >10g% 41 82 
 
 
In our study, majority of 42 cases (82%) did not have anemia as a feature. Only 
9 cases (18%) had haemoglobin less than 10mg/dl. 
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TOTAL LEUCOCYTE 
COUNT 
NO. OF PATIENTS 
(n=50) 
PERCENTAGE (%) 
 <4000/cumm 
 
5 10 
 4000-
10000/cumm 
 
41 82 
 >10000/cumm 4 8 
 
 
41 cases or 82% had normal leucocyte counts between 4000-11000 
cells/cumm.Only 5 cases or 10% had leucopenia with cells <4000/cumm and 
only 4 cases or 8% had leucocytosis with cells >11000/cumm.  
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NEUTROPHILS NO. OF CASES(n=50) PERCENTAGE (%) 
<60% 4 8 
60-80% 41 82 
>80% 5 10 
 
 
In our study,41 cases or 82% had normal neutrophil count of 60-80% whereas 4 
cases or 8% had neutropenia with neutrophils <60% and 5 cases or 10% had 
neutrophilia with neutrophils >80%. 
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LYMPHOCYTES 
LYMPHOCYTES NO. OF CASES(n=50) PERCENTAGE (%) 
<20% 4 8 
20-40% 24 48 
>40% 22 44 
  
 
In our study 24 cases or 48% had normal lymphocyte counts between 20-40% 
and 22 cases or 44% had lymphocytosis  with lymphocyted >40%.4 cases or 8% 
had lymphopenia with <20% lymphocytes.  
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PLATELET COUNT 
PLATELETS NO. OF CASES(n=50) PERCENTAGE 
<1.5 lakhs/cumm 11 22 
1.5-4 lakhs/cumm 36 72 
>4 lakhs/cumm 3 6 
 
36 cases or 72% had normal platelet counts between 1.5-4 lakhs/cumm and 11 
cases or 22% had thrombocytopenia with counts less than 1.5lakhs/cumm.3 
cases  or 6% had thrombocytosis with counts more than 4 lakhs/cumm. 
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ESR 
ESR NO. OF 
PATIENTS(n=50) 
PERCENTAGE (%) 
<=20 MM/1
ST
 HOUR 13 26 
>20 MM/1
ST
 HOUR 37 74 
 
 
37 cases or 74% had raised ESR (>20mm/1
st
 hour) at presentation and only 13 
or 26% had normal ESR in our study.  
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COMPARISON OF WIDAL WITH BLOOD CULTURE (n=86) 
        BLOOD CULTURE TOTAL 
POSITIVE NEGATIVE  
 
WIDAL 
POSITIVE 21 6 27 
NEGATIVE 29 30 59 
                    TOTAL    50 36 86 
 
In the above 2 X 2 contingency table, the Chi-square 6.236 for the association 
between the Widal test and the Blood culture test is significant (P< 0.01).  It can 
be inferred that there is a significant difference in the two tests.  Out of the 50 
blood cultured positive cases which was considered as the gold standard, was 
compared with the Widal test and only 21 cases showed positive and 29 
negative results.   6 cases out of 36 negative cases in blood test showed positive 
in  Widal test.  The Widal test has a Sensitivity of 77%: specificity of 51 % ; 
Positive predictive value of 58% and Negative predictive value of 16% when 
compared with blood culture result. 
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WIDAL REACTION IN BLOOD CULTURE POSITIVE PATIENTS 
WIDAL REACTION 
in Blood culture positive 
patients 
NO. OF CASES (n=50) PERCENTAGE (%) 
POSITIVE 21 42 
NEGATIVE 29 58 
TOTAL 50 100% 
 
WIDAL TITRE T O 
WIDAL TITRE FREQUENCY PERCENTAGE (%) 
<=1:80 32 64 
1:160 6 12 
1:320 7 14 
>= 1:640 5 10 
TOTAL 50 100 
  
WIDAL TITRE T H 
WIDAL TITRE FREQUENCY (n=50) PERCENTAGE (%) 
<=1:80 33 66 
1:160 6 12 
1:320 7 14 
>=1:640 4 8 
TOTAL 50 100 
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The Widal test was done at presentation.Of the 50 blood culture positive 
cases,Widal test was positive in 21 cases (42%), and negative in 29 cases 
(58%). Titres more than or equal to 1:160 were taken as positive.O agglutin was 
positive in the ratio 1:160 in 12%, 1:320 in 14%  and  ≥1:640 in 10%.H 
agglutinin was positive in the ratio 1:160 in 12%,1:320 in 14% and ≥1:640 in 
8%. 
 
 
 
 
21, 42%
29, 58%
WIDAL TEST IN BLOOD CULTURE POSITIVE 
PATIENTS
POSITIVE
NEGATIVE
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DURATION OF HOSPITAL STAY 
DURATION OF 
HOSPITAL STAY IN 
DAYS 
NO. OF CASES (n=50) PERCENTAGE (%) 
0  6 12 
1-7 25 50 
8-14 17 34 
>14 2 4 
 
 
6 cases or 12% did not require admission,25 cases or 50% were admitted for 
less than or equal to a week,17 cases or 34% were admitted for 8-14 day and 
only 2 cases or 4% required admission more than 2 weeks.Of the 50 cases,only 
7 required intensive unit care.  
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DRUG SENSITIVITY PATTERN 
ANTIBIOTIC 
(n=50) 
NO. OF CASES 
SENSITIVE 
PERCENTAGE 
(%) 
 AMPICILLIN 48 96 
 CHLORAMPHENICOL 49 98 
 CEFTRIAXONE 50 100 
 COTRIMOXAZOLE 48 96 
 CIPROFLOXACIN 47 94 
 NALIDIXIC ACID 4 8 
 
In our study,all the cases were responsive to Ceftriaxone,most were responsive 
to Ampicillin (48 cases,96%), Chloramphenicol (49 cases,98%),Cotrimoxazole 
(48 cases,96%) and Ciprofloxacin (47 cases,94%).Out of 50,only 4 cases 
responded to Nalidixic acid ie only 8% were sensitive.Therefore a total of 46 
cases were resistant to Nalidixic acid ie 92% were resistant to it.  
0
5
10
15
20
25
30
35
40
45
50
48 49
50
48 47
4
72 
 
RESPONSE OF FEVER TO ANTIBIOTIC THERAPY 
DAY OF 
SUBSIDENCE OF 
FEVER 
FOLLOWING 
INITIATION OF 
ANTIBIOTIC 
THERAPY 
 
NO. OF CASES 
(n=50) 
PERCENTAGE 
(%) 
Day 0 0 0 
Day 1 0 0 
Day 2 1 2 
Day 3 9 18 
Day 4 12 24 
Day 5 15 30 
Day 6 3 6 
Day 7 2 4 
>=Day 8 8 16 
TOTAL 50 100 
 
 
Following initiation of antibiotic therapy,majority (72%) had subsidence of 
fever from day 3 to day 5.None of the cases had defervescence before initiation 
0
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of antibiotics or on day 1 of initiation.8 cases or 16% responded only after more 
than a week of antibiotic therapy. 
The mean period of defervescence was 4.96 days.A minimum of 2 days and 
maximum of 8 days is noted.A standard deviation of 1.689 is seen. 
Of  the 50 cases,Ceftriaxone was the antibiotic given to 38 patients and the other 
12 received Ciprofloxacin. 
  
74 
 
RESPONSE TO CEFTRIAXONE 
DAY OF 
SUBSIDENCE OF 
FEVER 
FOLLOWING 
INITIATION OF 
CEFTRIAXONE 
NO. OF CASES 
(n=38) 
PERCENTAGE 
(%) 
Day 0 0 0 
Day 1 0 0 
Day 2 1 2.63 
Day 3 7 18.42 
Day 4 9 23.68 
Day 5 12 31.57 
Day 6 2 5.26 
Day 7 1 2.63 
>=Day 8 6 15.78 
TOTAL 38 100 
 
In the patients who received Ceftriaxone,there was defervescence of  fever 
mainly between days 3 to 5 and amounted to 73.67%.15.78 % of cases took 
atleast a week to respond.  
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RESPONSE TO CIPROFLOXACIN 
DAY OF 
SUBSIDENCE OF 
FEVER 
FOLLOWING 
INITIATION OF 
CIPROFLOXACIN 
 
NO. OF CASES 
(n=12) 
PERCENTAGE 
(%) 
Day 0 0 0 
Day 1 0 0 
Day 2 0 0 
Day 3 2 16.66 
Day 4 3 25 
Day 5 3 25 
Day 6 1 8.33 
Day 7 1 8.33 
>=Day 8 2 16.66 
TOTAL 12 100 
 Of the patients who were on Ciprofloxacin,66.66% responded by days 3-
5.16.66% of  patients took atleast a week to respond. 
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DISCUSSION 
 
 This study was conducted as a retrospective observational study among 
the  inpatients and outpatients  of the department of  Paediatrics of PSG IMSR  
with confirmed diagnosis of Salmonella typhi including locales in and around 
Coimbatore and also including referred cases.The study spanned over a period 
of 18 months from June 2011 to November 2012. 
 
 Of the 50 cases included in the study,26 cases (52%) fell in the age 
group of 11-15 years.26% ie 13 cases were of the 6-10 years age group and 22% 
or 11 cases were of the 0-5 years age group.There was only a single infant 
case.Walia et al
56
 reported that 21.7% were children aged under 5 years and 
6.1% were under 2 years.Yaramis et al
54
 reported that 17% of patients were 
children under 5 years and that school children were most affected. 
 
 Sinha A et al
4
 and Leon Ochiai et al
2
 reported that the incidence in 
preschool children and school going children were similar. 
 
 In our study, 36 out of the 50 cases were males and amounted to 72% 
and only 14 cases were females and amounted to only 28% .Males were 
predominant in the studies by Yaramis et al
54
,Garg K et al
19
 and Raghuram et 
al
38
. 
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Out of the 50 cases included in the study, majority of the cases were of 
the age group 11-15 years and of them 19 were male and only 7 were female.In 
all 3 selected age groups,males were the majority. 
34 of the 50 cases ie 68% had fever of 1-7 days prior to admission.Only 
10% had fever of more than 2 weeks duration. 
Comparison of presenting symptoms in various studies in percentage 
SYMPTOMS K.Garg 
et al
19 
R.K.Arora 
et al
26 
Sharma, 
Gathwala
39 
Bhutta
20 
Present 
study 
FEVER 100 100 100 95 100 
CHILLS 39 42.7 45 - 12 
VOMITING 41 30 29 39 46 
HEADACHE - 28.1 - 12 10 
PAIN 
ABDOMEN 
28 - - 28 22 
DIARRHOEA - 14.5 9.2 35 24 
CONSTIPATION - - 1.5 11 - 
GI BLEED - - - - - 
BURNING 
MICTURITION 
- - - - 4 
COUGH 36 37.8 29.2 - 28 
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All the cases presented with fever which is consistent with the findings of 
K.Garg et al,R.K Arora et al and Sharma,Gathwala.Bhutta 
22 
reported fever in 
95% of cases only. 
In our study 12% also had associated chills which is much lesser than that 
reported by K.Garg, R.K Arora and Sharma. 
  Vomiting was a complaint in 46% and is consistent with K.Garg’s and 
Bhutta’s22 study though it is much higher than studies by RK Arora and 
Sharma.Diarrhoea was seen in 24% and has a higher incidence in our study 
compared to all except Bhutta.Pain abdomen was present in 28% which is 
consistent with the findings of K.Garg and Bhutta.Cough was also seen in 28% 
which is similar to Sharma’s findings but lesser than that of K.Garg and R.K 
Arora.Few cases also reported nausea,headache,loss of appetite,joint pains and 
dysuria.None of  the cases had constipation,GI bleed or skin rashes which is 
similar to K.Garg
19
,RK Arora
26
 and Sharma
39
.Bhutta
20
 reported constipation in 
11%. 
Vomiting as a symptom was more common in the age group 6-10yrs 
old.Diarrhoea was less common in 0-5 yrs old compared to the other 2 age 
groups.Pain abdomen was a complaint mainly in the 6-10 yrs and 11-15 yrs age 
group.Cough was most common in 11-15 yrs old.Joint pain and dysuria were 
seen only in 6-10 yrs age group.  
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COMPARISON OF SIGNS WITH SIMILAR STUDIES IN 
PERCENTAGE 
SIGNS K.Garg 
et al
19 
R.K.Arora 
et al
26 
Raghur
aman 
et al
38 
Bhutta 
20 
Present 
study 
PYREXIA 100 100 100 95 100 
TOXIC LOOK 28 39.8 30 33 16 
COATED TONGUE - 33 - - 6 
PALLOR 10 57.2 - - 4 
JAUNDICE 1.4 1 6 2 2 
ROSE SPOTS - - -  - 
SPLENOMEGALY 55 90 45 20 26 
HEPATOMEGALY 60 45.6 88 41 48 
LYMPHADENOPATHY - - - - - 
CHEST SIGNS - 8.7 - - - 
CNS COMPLICATIONS - - - - - 
CVS COMPLICATIONS - - - - - 
 
All the cases had pyrexia in our study which is consistent with the other 3 
studies except Bhutta who reported pyrexia in 95% of cases.Only 16% had a 
toxic look which is lesser than that in studies of K.Garg, RK Arora, 
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Raghuraman and Bhutta.Coated tongue was seen in 6 percent,pallor in 4% and 
jaundice in 2%.Hepatomegaly was a feature in 48% which is similar to RK 
Arora and Bhutta  and lesser than that of K.Garg and Raghuraman.In our study 
splenomegaly was noted in 26% which is lesser than the other three studies 
except Bhutta who reported it in 20%.1 case had joint swelling.None of the 
cases included had rose spots,lymphadenopathy, chest signs, CNS or CVS 
complications which is similar to the other 4 studies. 
Splenomegaly was more common in 11-15 yrs age group.Pallor and 
jaundice were noted only in 6-10yrs age group.Joint swelling was found in only 
1 case and was of 0-5 yrs age group.Most other signs had almost equal 
distribution. 
Sinha A et al reported that typhoid may present in a more dramatic form 
in children less than 5 years old with higher rates of complications and 
hospitalizations.
4
 
45 of the cases (90%) had  temperatures falling within 99-102 ⁰F.None of 
the cases had temperatures more than 103 ⁰F. 
In our study,majority (82%) did not have anemia as a feature. Only 9 
cases (18%) had haemoglobin less than 10mg/dl. Yaramis  et al
54
 reported 
anemia in 38% of cases.In cases of severe fall in haemoglobin levels,one should 
rule out gastrointestinal bleed or hemolysis or an alternative diagnosis. 
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82% of the cases had normal leucocyte counts and only 10% had 
leucopenia and only 8% had leucocytosis. Sinha A
4
 and Bhutta ZA
20,22
  reported 
blood leucocye counts to be low in relation to fever and toxicity but the range is 
wide and they also reported leucocytosis upto 25,000cells/cumm in younger 
children.RA Garg reported leucopenia in 16.7% and RK Arora reported it in 
10.7%. 
In our study,82% had normal neutrophil count whereas 8% had 
neutropenia and 10% had neutrophilia. 
44% had lymphocytosis and 48% had normal lymphocyte counts. 
72% had normal platelet counts,22% had thrombocytopenia and 6% had 
thrombocytosis.Yaramis reported thrombocytopenia in 10%. 
75% had raised ESR at presentation and only 26% had normal ESR in our 
study. 
Widal test was compared with blood culture in the 86 initially chosen 
casesheets and the Chi-square 6.236 for the association between the Widal test 
and the Blood culture test is significant (P< 0.01).  Thus it can be inferred that 
there is a significant difference in the two tests.  The 50 blood cultured positive 
cases, which was considered as the gold standard, was compared with the Widal 
test and only 21 cases showed positive and 29 negative results.   6 cases out of 
36 negative cases in blood test showed positive in  Widal test.  The Widal test 
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has a Sensitivity of 77%: specificity of 51 % ; Positive predictive value of 58% 
and Negative predictive value of 16% when compared with blood culture 
result.Yaramis et al 
54 
reported that of the 67 patients with blood culture positive 
for S.typhi in their study,23 also had positive Widal serology. Olsen et al
60
 and 
Parry
61
 et al reported that though the Widal test is commonly used for the 
diagnosis of typhoid fever,it is unreliable especially in endemic areas. 
Of the 50 blood culture positive cases,Widal test was positive in 21 cases 
(42%), and negative in 29 cases (58%). Titres more than or equal to 1:160 were 
taken as positive.O agglutin was positive in the ratio 1:160 in 12%, 1:320 in 
14%  and  ≥1:640 in 10%.H agglutinin was positive in the ratio 1:160 in 
12%,1:320 in 14% and ≥1:640 in 8%. 
Parry et al
61
 reported that O-agglutinin titer was ≥100 in 83% of the blood 
cuture positive typhoid fever cases and H-agglutinin titer was ≥ 100 in 67%.71 
Yaramis et al reported that of the 23 patients with positive Widal and blood 
culture,agglutination titers of at least 160 were positive in all children.
54 
In our study,all the cases were responsive to Ceftriaxone (100% 
sensitive).Chowta et al
64
 and Jog et al
66
 also had similar results. Most were 
responsive to Ampicillin (48 cases,96%), Chloramphenicol (49 
cases,98%),Cotrimoxazole (48 cases,96%) and Ciprofloxacin (47 
cases,94%).Out of 50,only 4 cases responded to Nalidixic acid.Thus there was 
92% resistance for Nalidixic acid in our study.Significant resistance to Nalidixic 
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acid was also noted in studies by Jog S et al
66
 and Walia M et al 
67
. Walia et al 
reported that Nalidix acid resistance is a marker for the prediction of  low level 
resistance of ciprofloxacin among Salmonella typhi and also an indicator of 
treatment failure to ciprofloxacin.The CLSI now recommends tha all S.typhi 
isolates are to be screened for nalidixic acid resistance along with 
ciprofloxacin
62
.Nagshetty et al
63
 reported that Nalidixic acid resistance was 
reported in 31.5% and was associated with an increase in Ciprofloxacin MIC. 
Majority of cases responded to antibiotic therapy within days 3 to 5 of 
initiation.16% responded only after more than a week of antibiotics. The mean 
period of defervescence was 4.96 days.A minimum of 2 days and maximum of 
8 days is noted.A standard deviation of 1.689 is seen. 
Of  the 50 cases,Ceftriaxone was the antibiotic given to 38 patients and 
the other 12 received Ciprofloxacin. 
Kumar R,Gupta N and Shalini conducted a study to evaluate multi drug 
resistant typhoid fever and therapeutic response of ofloxacin and ceftriaxone 
and reported that hose children treated with ceftriaxone had a shorter time to 
defervescence compared to ofloxacin with a mean of 4.258 and 4.968 
respectively.
24
 
12% did not require admission for treatment.50% were admitted for less 
than or equal to a week.34% for 8-14 days and 4% for more than 2 weeks. 
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CONCLUSION 
 
50 cases were included in our study.Of them 52% were of the age group 11-15 
years. 
 
Males were predominant in all 3 age groups. 
 
All the cases included presented with fever,majority of whom had fever of less 
than or equal to a week at presentation. 
 
Other common symptoms were chills,headache,vomiting, diarrhoea and cough. 
 
Pyrexia was noted in all patients and other common signs were toxic 
look,hepatomegaly and splenomegaly. 
 
Majority had normal leucocyte counts with relative lymphocytosis. 
 
Widal test is a simple,fast,cheap and easily available test though its reliability is 
not recommendable as not all patients with blood culture positive for 
Salmonella showed a positive Widal.However there is a significant association 
between blood culture and Widal test. 
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Majority of the cases were resistant to Nalidixic acid and is thus not 
recommended at present.Nalidixic acid resistance also implies that a higher dose 
of Ciprofloxacin is required.All the cases were sensitive to Ceftriaxone.Most 
were responsive to Ampicillin,Chloramphenicol,Cotrimoxazole and 
Ciprofloxacin. 
 
Majority of cases responded to antibiotic therapy within days 3 to 5 of initiation. 
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CASE SHEET PROFORMA 
 
Name: 
Age: 
Sex: 
Address: 
IP No. : 
Presenting complaints: 
H/o Presenting illness: 
Fever-duration, continuous/remittent/intermittent,low/moderate/high,treatment 
GI symptoms- nausea,vomiting,loss of appetite,pain 
abdomen,distension,diarrhoea,constipation,bleed etc 
Jaundice 
Headache 
Urine-dysuria,discoloration,frequency 
Respiratory symptoms-Cough 
Joint pains 
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CNS symptoms-abnormal movements,altered sensorium,weakness etc 
Past History: 
Treatment History: 
Family History: 
Personal History: 
Immunization History: 
Socioeconomic History: 
GENERAL EXAMINATION: 
Toxic look- 
Pulse- 
Blood pressure- 
Temperature- 
Respiratory Rate- 
Pallor- 
Icterus- 
Lymphadenopathy- 
Coated tongue- 
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SYSTEMIC EXAMINATION 
GASTROINTESTINAL SYSTEM 
Inspection:Distension,visible veins,pulsations 
Palption: Tenderness,Guarding,Rigidity,Liver,Spleen 
Percussion: Shifting dullness 
Auscultation:Bowel sounds 
RESPIRATORY SYSTEM 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
CARDIOVASCULAR SYSTEM 
Inspection: 
Palpation: 
Percussion: 
Auscultation: 
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CENTRAL NERVOUS SYSTEM 
Higher Mental Functions: 
Skull and Spine: 
Cranial Nerves: 
Motor system: 
Sensory system: 
Signs of Meningeal irritation: 
Cerebellar signs: 
Blood Picture: Hemoglobin, Total leucocyte count, Differential count, ESR 
Widal test: Positive/ Negative, titer 
Blood Culture & sensitivity pattern for Salmonella typhi: 
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MASTER CHART 
 
       AMPI CHLOR
AM 
CEFTRI COTRI
MOX 
CIPRO NAL.
AC 
1 AASHISH .R I12002806 12 Y M + + S S S S S R 
2 GURUDEV I12003152 10 M M + + S S S S S R 
3 KISHOR 
KUMAR.R 
I12005792 4 Y M + - S S S S S R 
4 VIGNESH.S I12009795 3 Y 
3 M 
M + - S S S S S S 
5 SAHANAS I12017315 7 Y M + + S S S S S R 
6 SUDARSHA
N.S 
I12021226 8 Y M + - S S S S S R 
7 DHIYA.K I12023981 10 M F + + S S S S S R 
8 VARUN 
PRASATH.S 
I10000710 1 Y 
8 M 
M + - S S S S S R 
9 DEEPAK I10003085 6 Y 
3 M 
M + + S S S S S R 
10 GIRIDHARA
N.M 
I10011264 1O Y M + - S S S S S R 
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SI NAME REG.NO: AGE SE
X 
BLD 
CUL 
WIDAL ANTIBIOTIC SUSCEPTIBILITY 
AMPI CHLOR
AM 
CEFTRI COTRI
MOX 
CIPRO NAL.
AC 
11 GOKULAK
RISHNAN 
I10020430 10 Y M + - S S S S S S 
12 VANISRI.S.
R 
I10022478 10 Y 
5 M 
F + - S S S S R R 
13 KEERTHA
NA.L 
I10025265 12 F + - S S S S S R 
14 NANDHA.S
M 
I10026708 2 Y M + + S S S S S R 
15 NITHISH.V I10027727 5 Y 
5 M 
M + - S S S S S R 
16 VEDHANA
RAYANAN.
K 
I10029062 9 Y 
10 M 
M + + S S S S S R 
17 SANTHOSH I10031417 12 M + - S S S S S R 
18 ARUNACH
ALAM.E 
I10034261 10 Y 
3 M 
M + + S S S S S S 
19 MUGUNTH
AN.T 
I10035848 2 Y M + - R S S S S R 
20 SHYRO 
MARIYA.S 
I10047361 2 Y 
7 M 
F + - S S S S S R 
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SI NAME REG.NO: AGE SE
X 
BLD 
CUL 
WIDAL ANTIBIOTIC SUSCEPTIBILITY 
AMPI CHLOR
AM 
CEFTRI COTRI
MOX 
CIPRO NAL.
AC 
21 MEENA.K I10048364 4 Y F + + S S S R S R 
22 ADITHYA.M I10051018 9 Y 
6M 
M + - S S S S S R 
23 BHARANI 
PRASANTH  
I107010331 13 Y M + + S S S S S R 
24 RANJITH I07015124 12 Y M + + S S S S S R 
25 SHEEBA.M I07016249 8Y 
5M 
F + - S R S R R R 
26 SHINY 
ROMINA 
I07017003 8Y 
3M 
F + + S S S S S R 
27 LENDA 
CHRISTINA 
I070170271 12 Y F + + S S S S S R 
28 JENISHA I07018371 4Y 
8M 
F + - S S S S S R 
29 JOYLYDIA I07028159 7Y 
9M 
F + - S S S S S R 
30 MAHALAKS
HMI 
I12019525 14Y F + - S S S S S R 
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SI NAME REG.NO: AGE SE
X 
BLD 
CUL 
WIDAL ANTIBIOTIC SUSCEPTIBILITY 
AMPI CHLOR
AM 
CEFTRI COTRI
MOX 
CIPRO NAL.
AC 
31 THARUN O07003093 10Y 
8M 
M + - S S S S S R 
32 AJMAL I08002867 5Y M + - S S S S S R 
33 SHIVANI.L.
M 
I08011026 7Y F + - R S S S S R 
34 NASEEHA I08044122 8Y 
9M 
F + + S S S S S R 
35 JERVIN 
THEEYANO
SE 
I08047632 12Y M + - S S S S S R 
36 AJAY 
CHANDRAN
.S 
I09020609 5Y 
7M 
M + - S S S S S R 
37 DURGA 
PRASATH.R 
I09019187 15 Y M + + S S S S S S 
38 MOHAMME
D 
RIYASUDEE
N 
I09016971 8Y M + - S S S S S R 
39 HARISH I09016948 12Y M + + S S S S S R 
40 DINESH.D I11033985 11Y M + + S S S S S R 
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SI NAME REG.NO: AGE SE
X 
BLD 
CUL 
WIDAL ANTIBIOTIC SUSCEPTIBILITY 
AMPI CHLOR
AM 
CEFTRI COTRI
MOX 
CIPRO NAL.
AC 
41 ANTONY.D I11014439 8Y M + - S S S S S R 
42 VINDHYA.M I11017041 11Y F + + S S S S S R 
43 EBINEZAR I11013759 11Y M + - S S S S S R 
44 SABARI 
PRASANNA 
I11011217 10 Y M + + S S S S S R 
45 DHIVYA.G.B I11003828 4Y F + - S S S S S R 
46 MATHAN.D I11002198 7Y3M M + + S S S S S R 
47 NETHRA.M O10096185 2Y6M F + - S S S S S R 
48 INIYAN.A.S O07087311 9Y4M M + + S S S S S R 
49 YOGESH.M I11018073 9Y6M M + - S S S S R R 
50 SRE 
SOORYA.K.P 
I07037407 14Y M + - S S S S S R 
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SI NAME SYMPTOMS SIGNS 
Fe Ch Na Vo He Lo Di Cn PA GIb Ra Cg Jt Dy Py Tx Ct Pa Ja Ro Ly Li Sp Js RS CN CV 
1 AASHISH .R + - - - - - + - - - - - - - + - - - - - - + + - - - - 
2 GURUDEV + - - + - - - - + - - - - - + - + - - - - - - - - - - 
3 KISHOR 
KUMAR.R 
+ - + - + - - - - - - + - - + + - - - - - - - - - - - 
4 VIGNESH.S + - - - - - - - - - - - - - + - - - - - - + + - - - - 
5 SAHANAS + + - - - - + - - - - - - - + - - + - - - + - - - - - 
6 SUDARSHAN.S + - - + - - + - - - - - - - + - - - - - - - - - - - - 
7 DHIYA.K + - - - - - - - - - - + - - + - - - - - - + - - - - - 
8 VARUN 
PRASATH.S 
+ - - - + - - - - - - - - - + - - - - - - - + - - - - 
9 DEEPAK + - - + - - - - - - - - - - + - - - - - - + - - - - - 
10 GIRIDHARAN.M + - - + - - - - - - - + - - + - - - - - - - - - - - - 
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SI NAME SYMPTOMS SIGNS 
Fe C
h 
Na V
o 
He L
o 
D
i 
C
n 
P
A 
GI
b 
R
a 
C
g 
Jt D
y 
P
y 
T
x 
Ct Pa Ja R
o 
L
y 
L
i 
Sp Js R
S 
C
N 
CV 
11 GOKULAKRISHNA
N 
+ - - + - - + - - - - - - - + - - - - - - + - - - - - 
12 VANISRI.S.R + - - - - - - - + - - - - - + - - - - - - - - - - - - 
13 KEERTHANA.L + - - - - - - - - - - + - - + + - - - - - + + - - - - 
14 NANDHA.SM + + - - + - - - - - - - - - + - - - - - - + - - - - - 
15 NITHISH.V + - - + - + + - + - - - - - + - - - - - - + - - - - - 
16 VEDHANARAYAN
AN.K 
+ - - + - - - - - - - - - - + - + - - - - - - - - - - 
17 SANTHOSH + - - + - - + - - - - + - - + - - - - - - + + - - - - 
18 ARUNACHALAM.E + - - - - - - - + - - - - - + - - - + - - - + - - - - 
19 MUGUNTHAN.T + + - + + - - - - - - - - - + + - - - - - + - - - - - 
20 SHYRO MARIYA.S + - - + - - - - - - - - - - + - - - - - - + - - - - - 
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SI NAME SYMPTOMS SIGNS 
Fe Ch Na Vo He Lo Di Cn PA GIb Ra Cg Jt Dy Py Tx Ct Pa Ja Ro Ly Li Sp Js RS CN CV 
21 MEENA.K + - - -  - - - - - - - - - + - - - - - - - - - - - - 
22 ADITHYA.M + - - + - - - - - - - - - - + - + + - - - + + - - - - 
23 BHARANI 
PRASANTH  
+ - - - - - - - - - - + - - + - - - - - - + - - - - - 
24 RANJITH + - - + - - + - + - - - - - + - - - - - - - - - - - - 
25 SHEEBA.M + - - - - - - - - - - - - - + - - - - - - - - - - - - 
26 SHINY ROMINA + - - + - - + - - - - - - - + - - - - - - - + - - - - 
27 LENDA 
CHRISTINA 
+ - - - - - - - + - - - - - + - - - - - - + - - - - - 
28 JENISHA + - - - - - + - - - - - - - + - - - - - - + - - - - - 
29 JOYLYDIA + + - + - - - - - - - - - - + + - - - - - - - - - - - 
30 THARUNESWAR.J + - - - - - - - - - - + - - + - - - - - - + + - - - - 
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SI NAME SYMPTOMS SIGNS 
Fe Ch Na Vo He Lo Di Cn PA GIb Ra Cg Jt Dy Py Tx Ct Pa Ja Ro Ly Li Sp Js RS CN CV 
31 THARUN + - - + - - - - + - - - - - + - - - - - - - - - - - - 
32 AJMAL + + - - - - - - - - - - - - + - - - - - - + - - - - - 
33 SHIVANI.L.M + - - + - - + - - - - + - - + + - - - - - - - - - - - 
34 NASEEHA + - - - - - - - + - - - - + + - - - - - - + + - - - - 
35 JERVIN 
THEEYANOSE 
+ - - + - + - - - - - + - - + + - - - - - - - - - - - 
36 AJAY 
CHANDRAN.S 
+ - - + - - - - - - - - - - + - - - - - - + - - - - - 
37 DURGA 
PRASATH.R 
+ - - - - - - - - - - + - - + - - - - - - - - - - - - 
38 MOHAMMED 
RIYASUDEEN 
+ - - + - - - - + - - - - - + - - - - - - + - - - - - 
39 HARISH + - - - - - + - - - - - - - + - - - - - - - + - - - - 
40 DINESH.D + - - + - - - - - - - - - - + - - - - - - - - - - - - 
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SI NAME SYMPTOMS SIGNS 
Fe Ch Na Vo He Lo Di Cn PA GIb Ra Cg Jt Dy Py Tx Ct Pa Ja Ro Ly Li Sp Js RS CN CV 
41 ANTONY.D + - - - - - - - - - - - - - + - - - - - - - - - - - - 
42 VINDHYA.M + - - + - - + - + - - - - - + + - - - - - - + - - - - 
43 EBINEZAR + - - - - - - - - - - + - - + - - - - - - + + - - - - 
44 SABARI 
PRASANNA 
+ - - - - - - - - - - - - + + - - - - - - - - - - - - 
45 DHIVYA.G.B + - - + - - - - - - - + - - + - - - - - - - - - - - - 
46 MATHAN.D + - - - - + - - + - - - - - + - - - - - - + - - - - - 
47 NETHRA.M + - - - - - - - - - - - + - + - - - - - - - - + - - - 
48 INIYAN.A.S + - + + - - - - - - - + - - + - - - - - - - - - - - - 
49 YOGESH.M + - - - - - - - - - - + - - + - - - - - - + - - - - - 
50 SRE 
SOORYA.K.P 
+ + - - +- - - - - - - - - - + + - - - - - - - - - - - 
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MASTER CHARTS KEY WORDS 
 
BLD CUL    - BLOOD CULTURE 
AMPI   - AMPICILLIN  
CHLORAM   - CHLORAMPHENICOL 
CEFTRI   - CEFTRIAXONE 
COTRIMOX              - COTRIMOXAZOLE 
CIPRO                        - CIPROFLOXACIN 
NAL.AC                     - NALIDIXIC ACID 
Fe                                - FEVER 
Ch                               - CHILLS 
Na                               - NAUSEA 
Vo                               - VOMITING 
He                               - HEADACHE 
Lo                               - LOSS OF APPETITE 
D                                - DIARRHEA 
Cn                              - CONSTIPATION 
PA                              - PAIN ABDOMEN 
GIb                            - G.I.BLEED 
Ra                              - RASH  
Cg                               - COUGH 
Jt                                 - JOINT PAIN 
Dy                               - DYSURIA 
Py                                - PYREXIA 
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Tx                                - TOXIC LOOK 
Ct                                 - COATED TONGUE 
Pa                                 - PALLOR 
Ja                                  - JAUNDICE 
Ro                                 - ROSE SPOTS 
Ly                                 - LYMPHADENOPATHY 
Hep                               - HEPATOMEGALY   
Sp                                 - SPLENOMEGALY 
Js                                  - JOINT SWELLING 
CV                               - CARDIOVASCULAR SYSTEM 
RS                               - RESPIRATORY SYSTEM 
CN                              - CENTRAL NERVOUS SYSTEM 
GIb                             - G.I.BLEED 
 
 
 
 
